VAS Correlation With BMI
Primary Purpose
Morbid Obesity
Status
Unknown status
Phase
Phase 4
Locations
Turkey
Study Type
Interventional
Intervention
Morphine
Sponsored by
About this trial
This is an interventional treatment trial for Morbid Obesity focused on measuring morbid obesity, postoperative pain
Eligibility Criteria
Inclusion Criteria:
- patients undergoing abdominal surgery and who will be given PCA treatment for postoperative pain.
Exclusion Criteria:
- patients younger than 18 years old, patients with uncompensated diabetes or related polyneuropathy, patients receiving antidepressants or have a diagnosis of depression
Sites / Locations
- Cerrahpasa Medical SchoolRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm Type
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Arm Label
Group 5
Group IV
Group III
Group II
Group I
Arm Description
Patients with BMI > 50
Patients with BMI between 40 and 49.9
Patients with BMI between 35 and 39.9
patients with BMI between 30 and 34.9
Patients with BMI <30
Outcomes
Primary Outcome Measures
Pain Scores on the Visual Analog Scale
Correlation between the VAS Scores and BMI will evaluated
Secondary Outcome Measures
Full Information
NCT ID
NCT02017314
First Posted
December 8, 2013
Last Updated
December 16, 2013
Sponsor
Istanbul University
1. Study Identification
Unique Protocol Identification Number
NCT02017314
Brief Title
VAS Correlation With BMI
Official Title
Correlation of Postoperative VAS Values and Body Mass Index in Patients Undergoing Abdominal Surgery: A Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2013
Overall Recruitment Status
Unknown status
Study Start Date
November 2013 (undefined)
Primary Completion Date
March 2014 (Anticipated)
Study Completion Date
March 2014 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Istanbul University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of the study is to observe if any correlation between Body mass index and VAS values exists in patients who has gone under abdominal surgery.
Group I : Patients with BMI<30 Group II: Patients with BMI between 30 and 34.9 Group III: Patients with BMI between 35 and 39.9 Group IV: Patients with BMI between 40 and 49.9 Group V : Patients with BMI >50
After the end of surgery patients will be extubated and in the recovery room morphine PCA (patient-controlled analgesia) treatment will be started according to their adjusted body weight. When VAS values over 4,10 mg/kg Paracetamol IV will be used as an escape treatment. VAS values and Delivery and Demand of the PCA and additional need for analgesics will be recorded in the first 48 hours.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Morbid Obesity
Keywords
morbid obesity, postoperative pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group 5
Arm Type
Active Comparator
Arm Description
Patients with BMI > 50
Arm Title
Group IV
Arm Type
Active Comparator
Arm Description
Patients with BMI between 40 and 49.9
Arm Title
Group III
Arm Type
Active Comparator
Arm Description
Patients with BMI between 35 and 39.9
Arm Title
Group II
Arm Type
Active Comparator
Arm Description
patients with BMI between 30 and 34.9
Arm Title
Group I
Arm Type
Active Comparator
Arm Description
Patients with BMI <30
Intervention Type
Drug
Intervention Name(s)
Morphine
Primary Outcome Measure Information:
Title
Pain Scores on the Visual Analog Scale
Description
Correlation between the VAS Scores and BMI will evaluated
Time Frame
48 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients undergoing abdominal surgery and who will be given PCA treatment for postoperative pain.
Exclusion Criteria:
patients younger than 18 years old, patients with uncompensated diabetes or related polyneuropathy, patients receiving antidepressants or have a diagnosis of depression
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
guniz koksal, Ass.Prof
Phone
2124143000
Ext
21876
Email
gunizkoksal@hotmail.com
Facility Information:
Facility Name
Cerrahpasa Medical School
City
Istanbul
State/Province
Marmara
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
emre erbabacan, specialist
Phone
00905322067777
Email
emreerbabacan@hotmail.com
12. IPD Sharing Statement
Citations:
PubMed Identifier
10782177
Citation
Choi YK, Brolin RE, Wagner BK, Chou S, Etesham S, Pollak P. Efficacy and safety of patient-controlled analgesia for morbidly obese patients following gastric bypass surgery. Obes Surg. 2000 Apr;10(2):154-9. doi: 10.1381/096089200321668703.
Results Reference
background
Learn more about this trial
VAS Correlation With BMI
We'll reach out to this number within 24 hrs